ACE and neoplasm: Both the mice expressing increased WT ACE (Tg-ACE) and the Tg-NKO mice having an active C domain showed reduced B16 tumor growth (16% and 23% of WT tumor volume) similar to what is seen in ACE 10/10 mice.